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Abstract
Objectives: Although many nanomaterials are being used in academia, industry and daily life, there is little 
understanding about the effects of nanoparticles on the reproductive health of vertebral animals, including human 
beings. An experimental study was therefore performed here to explore the effect of calcium phosphate nanoparticles 
on both steroid hormone production and apoptosis in human ovarian granulosa cells.
Methods: Calcium phosphate nanoparticles uptaking was evaluated by transmission electron microscopy (TEM). The 
cell cycle was assessed with propidium iodide-stained cells (distribution of cells in G0/G1, S, and G2/M phases) by flow 
cytometry. The pattern of cell death (necrosis and apoptosis) was analyzed by flow cytometry with annexin V-FITC/PI 
staining. The expression of mRNAs encoding P450scc, P450arom and StAR were determined by RT-PCR. Progesterone 
and estradiol levels were measured by radioimmunoassay.
Results: TEM results confirmed that calcium phosphate nanoparticles could enter into granulosa cells, and distributed 
in the membranate compartments, including lysosome and mitochondria and intracellular vesicles. The increased 
percentage of cells in S phase when cultured with nanoparticles indicated that there was an arrest at the checkpoint 
from phase S-to-G2/M (from 6.28 +/- 1.55% to 11.18 +/- 1.73%, p < 0.05). The increased ratio of S/(G2/M) implied the 
inhibition of DNA synthesis and/or impairment in the transition of the S progression stage. The apoptosis rate of 
normal granulosa cells was 7.83 +/- 2.67%, the apoptotic rate increased to 16.53 +/- 5.56% (P < 0.05) after the cells were 
treated with 100 microM calcium phosphate nanoparticles for 48 hours. Treatment with calcium phosphate 
nanoparticles at concentrations of 10-100 microM didn't significantly change either the progesterone or estradiol 
levels in culture fluid, and the expression levels of mRNAs encoding P450scc, P450arom and StAR after 48 h and 72 h 
period of treatment.
Conclusion: Calcium phosphate nanoparticles interfered with cell cycle of cultured human ovarian granulosa cells 
thus increasing cell apoptosis. This pilot study suggested that effects of nanoparticles on ovarian function should be 
extensively investigated.
Background
Nanoparticles possess nanostructure-dependent proper-
ties due to their small size, chemical composition, surface
charge, solubility and/or shape [1]. Despite the wide
applications of nanomaterials, there is a serious lack of
information concerning the impact of manufactured
nanomaterials on human health and the environment.
Typically, the nanoparticles are small enough to penetrate
through very small capillaries into the human tissues and
cells. Because nanoparticles can pass through biological
membranes, they can affect the physiology of most cells,
including brain and testes [2-4]. Application of nanoma-
terials leads to considerable concern regarding its poten-
tial biological effects and toxicity in humans [5,6]. The
major toxicological concern is that some of the manufac-
tured nanomaterials are redox active [7,8], and some par-
ticles transport across cell membranes, especially into the
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sial.
Hydroxyapatite (HA, a kind of calcium phosphate)
nanoparticles are similar to human bone in chemical
composition and have long been appreciated for their
biocompatibility. HA is now one of the most widely used
materials in the bone-repairing field. Calcium phosphate
is the primary mineral phase of human and animal bone
and tooth. Such a mineral phase, with its plate-like or
needle-like shape, typically varies in size from a very few
to hundreds of nanometers. HA nanomaterial has also
been studied for various applications, including orthope-
dics, dentistry, and food science, with many research top-
ics involving the mineral's interaction with cells [10].
Reproduction is a complex biological process that is
particularly sensitive to environmental endocrine disrup-
tors. Many chemicals have negative impacts on gameto-
genesis and hormone reproduction by either directly
affecting germ cells and indirectly affecting on somatic
nursing cells [11]. Ovarian granulosa cells play a major
role in maintaining ovarian function, health, and female
fertility. Cadmium oxide at lower concentrations pro-
moted apoptosis rather than necrosis in the mammalian
germline stem cells, thus leaving the plasma membrane
intact [12]. Some intracellular organelles involved in ste-
roidogenesis were infiltrated and/or altered due to the
presence of the nanogold particles [11]. Calcium phos-
phate nanoparticles have been used clinically so that we
will study carefully their effect on the female reproductive
system and reproductive health in the future work.
The hypothesis has been made that HA nanopaticles
themselves and many regulatory agents delivered by this
kind of nanopaticles could have some effects on ste-
roidgenesis and follicular development and maturation in
vivo and in vitro. In this pilot paper, we firstly investigated
the effect of calcium phosphate nanoparticles itself on
hormone production and apoptosis in human granulosa
cells cultured in vitro.
Methods
Chemicals
A solution with a Ca/P ratio of 1.67 was prepared with 60
mM of Ca(NO3)2·4H2O and 36 mM of NaH2PO4·2 H2O
[10,13,14]. The solution was stirred vigorously and
heated to 85°C and then the same volume of concentrated
ammonium hydroxide solution (28-30% NH3) was
quickly added to the solution, which immediately
induced nanoparticle precipitation. The mixture was held
at 85°C for approximately 24 hours to ensure a complete
conversion of the starting material to HA. After fabrica-
tion, the mixture was then cooled to room temperature
and the liquid part was then diluted until the pH dropped
below 9 without any HA nanoparticles being lost. The
rod-like crystal was used in this study (Fig 1). The somall-
est was 20-30 nm, and particles less 10% were greater
than 100 nm. Dry particle of HA prepared is stable in
room temperature.
4-androstene-3,17-dione, Percoll and fetal bovine
serum (FBS) were purchased from Sigma-Aldrich (St.
Louis, MO). Collagenase Type I was obtained from Wor-
thington Biochemical Corp. (Lakewood, NJ). Antibiotic-
antimycotic preparation (penicillin, 10,000 IU/mL; strep-
tomycin, 10,000 mg/mL; amphotericin B, 25 mg/mL)
were purchased from Grand Island Biological Co. (Grand
Island, NY). HEPES was purchased from American Bio-
analytical (Natick, MA).
Cell culture
Isolation of granulosa cells
Granulosa cells for in vitro experimentation were col-
lected from infertilite women who undergoing IVF-ET
treatment [11,15]. The women's follicles were punctured
with a hypodermic needle to extrude granulosa cells into
dish, then, centrifuged (200 × g, 5 min) and resuspended
in DMEM/F12 containing antibiotics and 10% FBS. The
blood cells were separated by 50% Percoll and centrifuged
at 600 × g for 5 min. Written consent was provided by all
patients. The research project was approved by the
Human Research Ethics Committee of First Affiliated
Hospital, Nanjing Medical University.
Cell culture
Every time, we can get samples from 8-10 patients. Those
cells, after separated by Percoll, were pooled together, in
Figure 1 The morphology of hydroxyapatite nanoparticles. The 
nanoparticles were observed by transmission electron microscopy 
(TEM, JEOL-1400TEM, USA) with an acceleration voltage of 100 kV. The 
scale bar in the image is 100 nm.
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nated or be a low level. Cells were then cultured in
DMEM/F12 supplemented with l-glutamine (2 mL), 10%
FBS, penicillin (10,000 IU/mL), streptomycin (10,000 mg/
mL) and amphotericin B (25 mg/mL) at 37°C in an atmo-
sphere of 5% CO2. Cultures were carried out in 6-well
plates (Corning Glass Works, Corning, NY) and 12-well
plates. The cultured cells in the 12-well plates were used
for hormone analysis and those in the 6-well plates were
used for isolation of mRNAs and cell cycle analysis.
HA nanoparticles treatment
After an initial 72 h of culture in DMEM/F12 medium
with 10% FBS, the culture medium was carefully removed
and replaced with fresh medium. Next, the granulosa
cells were simultaneously exposed to different concentra-
tions of calcium phosphate nanoparticles. In addition, 4-
androstene-3,17-dione (final concentration, 500 nM) was
added into the granulosa cell medium as a substrate for
estrogen biosynthesis. Ethanol was added to the negative
control cells to exclude the effect of the dissolvent. All
experiments were duplicated 3 or 4 times. The experi-
ment of every batch was grouped as follows. Group I was
treated with only 4-androstene-3,17-dione as control;
Group II was treated with HA nanoparticles (10 μM) and
4-androstene-3, 17-dione; Group III was treated with HA
nanoparticles (100 μM) and 4-androstene-3,17-dione.
The culture medium in the 12-well plates was collected
after 48 h and stored at -80°C for hormone analysis. Cells
cultured in the 6-well plates were lysed with TRIzol and
stored at -80°C for mRNAs analysis. For each experiment
each assay was performed in triplicate. Cells cultured in
the 6-well plates were also fixed in 80% ethanol for cell
cycle analysis.
Cell preparation for TEM
Granulosa cells were exposed during 2 h, 4 h, 24 h, 48 h
and 72 h to nanoparticles (100 μM). They were fixed with
2.5% glutaraldehyde, post-fixed with OsO4 and dehy-
drated in graded concentrations of ethanol [8,9] then
embedded in Epon. Ultra-thin sections were cut (80 nm),
counterstained with lead citrate and uranyl acetate then
observed with a Philips CM 12 electron microscope at 80
kV.
Cell cycle analysis
5 × 105 granulosa cells were plated in 6-well plates and
incubated in DMEM/F12 with 0.5% FBS for 48 h to syn-
chronize the cells in G0/G1 phase by serum deprivation
[16,17]. Cells were then induced to re-enter the cell cycle
by incubation in fresh medium with the calcium phos-
phate nanoparticles at the final concentration (deter-
mined from the growth assay results) for a further 48 h.
The cellular DNA content was determined by flow
cytometry, as described previously. We collected the
floating and attached cells using pancreatic enzyme and
resuspended them in DMEM/F12. The cells were fixed
for 30 min in an ice-cold 80% ethanol solution containing
ribonuclease (RNase, 2 mg/ml). We washed the cells in
PBS, and then stained them with propidium iodide (PI)
for 10 min. The PI-elicited fluorescence was measured for
individual cells using a flow cytometer (FACSCalibur,
Becton, Dickinson & Co., Tokyo, Japan) with laser excita-
tion at 488 nm. Emissions greater than 590 nm were col-
lected in a linear/log scale fashion. We analyzed a total of
1 × 106 cells for each sample and determined the percent-
ages of cells in G0/G1, S, and G2/M phases using stan-
dard ModiFIT and CELLQUEST software (Becton,
Dickinson & Co.).
Radioimmunoassay
The concentrations of progesterone and estradiol in
medium were assessed using commercially available
radioimmunoassay kits (Bei Fang Biotechnology Corp.,
Beijing, China) according to the manufacturer's protocol.
The intra-assay and inter-assay variations of the kits were
both less than 10%.
Semi-quantitative RT-PCR
After the supernatants were collected for steroid hor-
mone analysis, the cells in the corresponding wells were
harvested for mRNA extraction using Trizol reagent
according to the manufacturer's protocol. Extracted RNA
was treated with DNase prior to measuring RNA content
by spectrometry at OD260/280. Equal amounts of RNA
(500 ng) were reverse-transcribed into cDNA as previ-
ously described [18], using the following thermocycler
protocol: 70°C for 5 min and 42°C for 90 min.
The expression of P450scc, P450arom and StAR
mRNAs in the granulosa cells were measured by the
semi-quantitative RT-PCR. The primer pairs are shown
as follows: 1) P450scc: F: 5'-GTGACAATGGCTG-
GCTAA-3', R: 3'-GAGGAATCGTTCTGGGTT-5', 2)
P450arom: F: 5'-CACCTCTAACACGCTCTT-3', R: 3'-
AATCAACTCAGTGG CAAA-5, 3) StAR: F: 5'-
AGGAAGGACGAAGAACCA-3', R: 3'-CAGCCGAG
AACCGAGTAG-5'. PCR was performed in a total vol-
ume of 20 μl. β-Actin mRNA abundance served as an
internal control [18-21].
Statistical analysis
Data were expressed as mean ± SD from at least three
independent experiments. Statistical analysis was per-
formed using one-way analysis of variance (ANOVA) and
t test. Values were determined to be significant when P <
0.05.
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Effect of HA nanoparticles on granulosa cells
TEM examination was performed on granulosa cells post
2 h, 4 h, 24 h, 48 h and 72 h exposure to HA nanoparti-
cles. HA nanoparticles were observed in granulosa cells
(Fig. 2). Further analysis indicated that HA nanoparticles
were localized in the cytoplasm, mostly in membranate
compartments, including lysosome and mitochondria,
thecal organelles (Fig 2, arrow), besides particles existing
out of cells, surrounding cells. Compared with control
cells, no visible morphological changes were detected in
cells exposed to HA nanoparticles.
Flow cytometric analysis of cell cycle distribution and 
apoptosis
The cell cycle distribution was analyzed by MultiCycle
software to investigate the effect of calcium phosphate
nanoparticles on the cell cycle, as shown in Fig 3. Granu-
losa cells were treated with 10 and 100 μM concentra-
tions of calcium phosphate nanoparticles for 48 h. An
accumulation of cells in the S phases (from 6.28 ± 1.55%
to 11.18 ± 1.73%) was observed. Compared with control,
percentage of cells in G2/M phase in Group III increased
significantly (p < 0.05) (Fig. 3A). The apoptosis rate of
control group was 7.83 ± 2.67%, but the apoptotic popu-
lation significantly increased to 16.53 ± 5.56% after 48 h
treatment with 100 uM calcium phosphate nanoparticles
(P < 0.05) (Fig 4A). At the same time, the proportion of
the cells in S/(G2/M) phase increased perceptibly (0.89 ±
0.11% to1.38 ± 0.32%) (P < 0.05). The increased percent-
age of cells in the S phase when treated with HA nanopar-
ticles indicated that there was an arrest at the checkpoint
from phase S-to-G2/M, while an increase in the S/(G2/
M) ratio implied inhibition of DNA synthesis and/or
impairment in the transition or the S progression stage
(Fig. 3B).
Production of progesterone and estradiol and expression 
of mRNAs encoding P450scc, P450arom and StAR in 
granulosa cells after treatment with HA nanoparticles
As shown in Fig 4, treatment with calcium phosphate
nanoparticles at concentrations of 10 μM and 100 μM (48
h, 72 h) did not cause significant change in either proges-
terone and estradiol levels (Fig. 4A, P > 0.05), and in
expression of mRNAs encoding P450scc, P450arom and
StAR (Fig 4B, C). By semi-quantitative RT-PCR, we per-
formed a comparative analysis of gene expression in cul-
tured cells exposed to HA nanoparticles and those not
exposed (P > 0.05).
Discussion
Despite the potential benefits of nanotechnology, some
studies have indicated that certain nanoparticles might
cause adverse effects because of their small size and
unique properties [22]. For example, HA is now one of
the most widely used materials in the bone-repairing field
or used as medical adjuvant. Nanomaterials can enter
human tissues through several ports via the lungs after
inhalation [23], through the digestive system [24], and
possibly through the skin [25]. It has been confirmed that
nanoparticles could distributed and/or accumulated in
reproductive system, ovary and testis [2,3,22]. Due to
their small size, chemical composition, surface charge,
solubility and/or shape, nanoparticles could affect hor-
mone production and fertility, and reproductive health.
TEM observation suggested that calcium phosphate
nanoparticles entered into the cultured human granulosa
cells and located in thecal organelles within cytoplasm,
including lysosome and mitochondria besides particles
existing out of cells, surrounding cells (Fig 2). By our pro-
tocol prepared HA nanoparticles, two kinds of hydroxy-
apatite with different nanocrystal morphology were
obtained via a simple aqueous precipitation method
under different reactants molar ratios. Under Ca/P molar
ratio of 1.67/1, rod-like crystal was produced, while
under Ca/P molar ratio of 1.80/1, spherical crystal was
produced [13,14,21]. The rod-like crystal was used in this
Figure 2 TEM observation of granulosa cells exposed to calcium 
phosphate nanoparticles. Cells were exposed during 72 h to 100 μM 
of nanoparticles. Nanoparticles were internalized in cells and localized 
in cytoplasms, mostly in membranate compartments, including lyso-
some and mitochondria, thecal organelles (arrow). The scale bar in the 
image is 500 nm.
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temperature, we usually stored at 4°C in the refrigerator
for longer time over months. The suspended particles
were not stable within medium and within cell. Small par-
ticles could polymerizat while large particles could
schizolysis, totally, calcium phosphate nanoparticles in
medium trended to aggregation. So, the suspension of
HA nanoparticles in medium was freshly prepared once
before the beginning of the each experiment. Based on
others' modeling work, nanoparticles in 20-30 nm are
easier to penetrate cell walls and larger size make this
more difficult [11,26,27]. We found that HA nanoparti-
cles distributed in membranate compartments within
cells (Fig 2). It was also shown by others [13,14,21,28].
There are two kinds of endocytosis, phagocytosis and
pinocytosis [29,30] Phagocytosis is restricted to special-
ized cells such as macrophages, monocytes and neutro-
phils. Pinocytosis included macropinocytosis (for
particles > 1 μm), clathrin-mediated endocytosis (~120
nm), caveolin-mediated endocytosis (~60 nm) or clath-
rin- and caveolin-independent endocytosis (~90 nm).
Due to their size, HA nanoparticles agglomerates were
more likely to enter into cells through enter into cells
through composite endocytosis.
After treatment with different concentrations of cal-
cium phosphate nanoparticles for 48 h, an accumulation
of cells in the S, S/(G2/M) and apoptotic population
phases was observed (Fig 3). The cell cycle is a complex
process by which cells receive different growth control-
ling signals that are integrated and processed at various
points known as checkpoints [31]. The cell growth is con-
trolled when cells are not allowed to proceed further than
these checkpoints. Our data suggested that inhibition of
cell growth by HA nanoparticles mainly elicit change in
proliferation dynamics, the redistribution of cells along
the cell cycle. The increased apoptosis rate was linked to
cell cycle arrest. Cadmium oxide nanoparticles at lower
concentrations promoted apoptosis rather than necrosis
in the mammalian germline stem cells. Mitochondria
play a central role in the regulation of apoptotic signaling
[32-34]. Potential disord of mitochondria is one of the
earliest intracellular events that occur following induc-
Figure 3 Apoptotic population and flow cytometric analysis of granulosa cell cycle distribution. (A) Flow cytometric analysis of calcium phos-
phate nanoparticles induced apoptosis in granulosa cells using annexin V-FITC/PI. The x-axis represents fluorescent intensity on a logarithmic scale, 
whereas the y-axis represents the number of events: (A1) Control; (A2) Treatment with 10 μM calcium phosphate nanoparticles; (A3) Treatment with 
100 μM calcium phosphate nanoparticles; the green peak refers to the apoptotic population. (B C) The results were analyzed by Mod Fit LT 3.0; Data 
were presented as mean ± SD (n = 3). *p < 0.05, compared with the control group (0 μM).
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ticles could induce increase of cells arrest in S, S/(G2/M)
and increased apoptotic population by interferencing
mitochondrial structure and function [32,34] Intracellu-
lar free calcium level could also be increased by HA treat-
ment. Pezzatini S et al used HA concentrations ranging
from 2 to 10 μg/ml to study microvascular endothelial
cell [21]. Qiang Fu et al tried HA with 31.25 to 250 μg/ml
in Osteosarcoma U2-OS cell [14]. In our study, granulosa
cells were treated with HA nanoparticles at two concen-
trations of 10 and 100 μM, equally 5 and 50 μg/ml. HA
particles was suspensed in DMEM/F12 medium, pH did
not changed significantly. So, cell apoptosis was unlikely
resulted from the elevated alkaline by HA nanoparticles
in culture medium.
We evaluated steroid hormone production and mRNAs
expression encoding P450scc, P450arom and StAR in
granulosa cells exposed to HA nanoparticles for 48 h and
72 h (Fig 4). HA nanoparticles at 10 and 100 μM did not
significantly change progesterone and estradiol produc-
tion. Even though these results did not show the func-
tional disord as well as its molecular mechanisms in this
study, the effect of HA nanoparticles on ovarian function
should not be underestimated. Effects of nanoparticles on
ovarian function should be extensively investigated in
future. Stelzer et al recently reported that the amount of
estrogen was significantly increased by treatment with 10
nm nanogold particles (2.85 × 1010 particles/ml) for 1, 3, 5
h, conversely attenuated by treatment for 24 h, with rat
ovarian granulosa cells [11]. There were differences in
dosage, chemicals, particle size, and cell model between
our study and Stelzer's report. And the cell models were
different. Human luteinized granulosa cells have been
exposed to pharmacological doses of exogenous gonado-
tropins, being in the process of undergoing differentia-
tion to luteal cells with relatively limited capacity for cell
Figure 4 Effect of calcium phosphate nanoparticles on P450scc, P450arom and StAR mRNA expression in human granulosa cells in vitro. 
Granulosa cells were cultured as described in the text. Following the measurement of steroid hormone levels (A). RT- PCR was used to determine the 
expression of P450scc, P450arom and StAR mRNAs in the cultured granulosa cells after 48 h (B) and 72 h (C) with calcium phosphate nanoparticles. 
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from the unstimulated, human normal ovaries, these cells
cultured in vitro now are useful cell model, to study cell
cycle regulators, apoptosis, and related mechanisms
involved in human ovary granulosa cell [17].
In conclusion, calcium phosphate nanoparticles inter-
fered with cell cycle of cultured human ovarian granulosa
cells thus increasing cell apoptosis. HA nanoparticles
could enter into granulosa cells by many ways such as
directly penetrating and endocytosis, and were located in
thecal organelles, including lysosome and mitochondria.
Although hormone production of the cultured granulosa
cells was not significantly affected by 10 μM and 100 μM
HA nanoparticles within 48 h treatment, this pilot study
suggested that effects of nanoparticles on ovarian func-
tion should be extensively investigated.
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